Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
ICON announced it is working with Practice Fusion to leverage active patient data in support of health research.
read more
Axol Bioscience launch their Human iPSC-derived Atrial Cardiomyocytes for the discovery and development of novel treatments and advancing our understanding of cardiovascular disease.
read more
Eximia Research announced the integration of Tidewater Clinical Research into its national network of clinical trial sites. This strategic development unites Tidewater's longstanding expertise in Women's Health and Ophthalmology with Eximia's ...
read more
Tuesday, January 10, 2023
Premier Research and Centogene N.V. have announced a strategic partnership to provide end-to-end support in rare disease clinical trials. The collaboration aims to improve patient identification, stratification, recruitment, and enrollment, thereby ...
read more
Dr. Reddy’s Laboratories is voluntarily recalling four lots of Phytonadione Injectable Emulsion USP, 10 mg/mL, Single-Dose Ampules to the hospital level.
read more
PAREXEL International Corporation (Nasdaq: PRXL)(“PAREXEL” or the “Company”), a global clinical research organization, announced today that the Company has acquired all of the outstanding equity securities of ATLAS Medical Services (“ATLAS”), a ...
read more
Wednesday, September 30, 2015
Frontage, a full service contract research organization (CRO) located in the USA and China, has announced the expansion of its bioanalytical laboratories to meet increased demand for its services from existing and new biopharmaceutical clients.
read more
Monday, February 08, 2021
Noble has announced the launch of “Human Factors Plus” (HF+), an expanded service to further optimize the patient self-administration experience by supporting its customers.
read more
Almac Group has announced a £375,000 investment in additional NMR instrumentation at its global Headquarters, Craigavon, UK.
read more
Abdi Ibrahim has selected rfxcel to implement and support new compliance management and serialization processing software.
read more
Wednesday, August 07, 2019
Applied DNA Sciences has announced the signing of a Master Services Agreement with Germany-based Schreiner Group through its Schreiner MediPharm business unit.
read more
Thursday, September 12, 2019
Catalent has announced professor David Schaffer has been appointed to the advisory board of the company’s biologics business.
read more
Centinel Spine® announced FDA approval for the manufacturing transfer of both the prodisc® C Cervical Total Disc Replacement and prodisc® L Lumbar Total Disc Replacement systems to new vendors.
read more
Friday, November 06, 2020
Mylan and Pfizer announced the FTC accepted a proposed consent order, which concludes the FTC’s review of the proposed combination of Mylan and Pfizer’s Upjohn Business.
read more
Samsung Biologics signed a strategic partnership agreement with Kineta, Inc., a clinical-stage biotech company developing novel immunotherapies in oncology. Samsung Biologics will provide end-to-end CDMO service from cell line development, clinical ...
read more